MDXG Q1 2021 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$60M-2.9% YoY

Gross Profit

$50M83.9% margin

Operating Income

-$7M-11.4% margin

Net Income

-$8M-14.0% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-12.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$191M

Total Liabilities

$107M

Stockholders' Equity

$84M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$62M	-2.9%
Gross Profit	$50M	$52M	-2.7%
Operating Income	-$7M	-$14M	+50.1%
Net Income	-$8M	-$5M	-73.9%